EXPERIENCE YOU CAN TRUST
The firm specializes in complex, commercial litigation. The firm's principal, Joshua H. Grabar, has been involved in some of the largest class actions of the last two decades.
DEDICATION YOU CAN RELY ON
We take pride in providing effective and aggressive representation. Our reputation and history of success speaks for itself and drives lasting client relationships. We are here for you.
LET'S WORK TOGETHER
If you have suffered a financial loss as a result of securities fraud, price-fixing or consumer fraud, you can rest assured that we are on your side. If you are a business seeking to avoid unnecessary legal liability, or reduce the costs of compliance, we are your solution.
latest blog
Grabar Law Office Files Federal Antitrust Class Action Challenging Alleged Price-Fixing by Pepsico and Walmart
By Grabar Law |
Philadelphia, PA – December 23, 2025 – Grabar Law Office announced today that it has filed a federal antitrust class action lawsuit in the United States District Court for the Southern District of New York against PepsiCo and Walmart on behalf of merchants and retailers who directly purchased Pepsi soft drink products from PepsiCo. Plaintiff,…
Read More 
Grabar Law Office Files Suit on Behalf of The City of Charlotte Against Major Insulin Manufacturers and PBMs
By Grabar Law |
Grabar Law Office and Hausfeld LLP today announced the filing of a major federal lawsuit in the U.S. District Court for the District of New Jersey on behalf of the City of Charlotte against pharmaceutical giants Eli Lilly, Novo Nordisk, and Sanofi, along with the nation’s three largest pharmacy benefit managers (PBMs)—CVS Caremark, Express Scripts,…
Read More 
Grabar Law Office In The News: Fiber Optics Co. Agrees To Reforms To End Derivative Suit
By Grabar Law |
Fiber optic equipment company Luna Innovations Inc. has reached a deal with its investors to settle their derivative claims alleging the company was damaged by its failure to properly recognize revenue in its filings with the U.S.Securities and Exchange Commission. According to a motion filed Wednesday in California federal court, the calls for a host…
Read More 
Grabar Law Office In the News:Â Â Alto Neuroscience Execs Sued Over Rosy Drug Claims
By Grabar Law |
An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company’s lead drug candidate for treating major depressive disorder, according to a lawsuit filed Tuesday in California federal court that alleges the company’s stock price plummeted when the truth came out. From the time of Alto’s $120…
Read More